EverSource Wealth Advisors’s CryoPort CYRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$26K Sell
1,658
-167
-9% -$2.14K ﹤0.01% 2246
2026
Q1
$15.1K Buy
1,825
+125
+7% +$1.13K ﹤0.01% 2679
2025
Q4
$16.3K Buy
1,700
+191
+13% +$1.8K ﹤0.01% 2519
2025
Q3
$14.3K Hold
1,509
– – ﹤0.01% 2598
2025
Q2
$11.3K Buy
1,509
+929
+160% +$5.76K ﹤0.01% 2733
2025
Q1
$3.53K Buy
580
+447
+336% +$3.09K ﹤0.01% 2661
2024
Q4
$1.03K Buy
133
+47
+55% +$350 ﹤0.01% 2953
2024
Q3
$697 Buy
86
+38
+79% +$311 ﹤0.01% 2793
2024
Q2
$443 Buy
48
+36
+300% +$485 ﹤0.01% 2920
2024
Q1
$194 Buy
+12
New +$190 ﹤0.01% 2800
2022
Q2
– Sell
-78
Closed -$3K – 1752
2022
Q1
$3K Hold
78
– – ﹤0.01% 1406
2021
Q4
$5K Buy
+78
New +$5.4K ﹤0.01% 1249

Other funds holding CYRX

EverSource Wealth Advisors's CYRX Position: Q2 2026 in Review

EverSource Wealth Advisors reduced its CryoPort (CYRX) stake by 9.2% in Q2 2026, selling an estimated $2.14K and leaving 1,658 shares worth $26K. The position accounts for ﹤0.01% of the portfolio, ranked #2246.

EverSource Wealth Advisors first reported a position in CYRX in Q4 2021 and has held it in 12 quarters since. 184 funds tracked by Wall St. Rank hold CYRX as of Q2 2026.

  • EverSource Wealth Advisors held 1,658 shares of CryoPort worth $26K as of Q2 2026.
  • EverSource Wealth Advisors sold 167 CryoPort shares in Q2 2026, an estimated $2.14K.
  • CryoPort made up ﹤0.01% of EverSource Wealth Advisors's portfolio in Q2 2026, its #2246 holding.
  • EverSource Wealth Advisors first reported a position in CryoPort in Q4 2021 and has held it in 12 quarters since.
  • 184 funds tracked by Wall St. Rank held CryoPort as of Q2 2026.

Based on EverSource Wealth Advisors's 13F filing for Q2 2026, filed 24 Jul 2026.